TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.780
-0.020 (-1.11%)
At close: Aug 29, 2025, 4:00 PM
1.770
-0.010 (-0.56%)
After-hours: Aug 29, 2025, 4:04 PM EDT

Company Description

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.

The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.

It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

TELA Bio, Inc.
TELA Bio logo
CountryUnited States
Founded2012
IPO DateNov 8, 2019
IndustryMedical Devices
SectorHealthcare
Employees209
CEOAntony Koblish

Contact Details

Address:
1 Great Valley Parkway, Suite 24
Malvern, Pennsylvania 19355
United States
Phone484 320 2930
Websitetelabio.com

Stock Details

Ticker SymbolTELA
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$13.00
CIK Code0001561921
CUSIP Number872381108
ISIN NumberUS8723811084
Employer ID45-5320061
SIC Code3841

Key Executives

NamePosition
Antony KoblishCo-founder, Chief Executive Officer and Director
Jeffrey BlizardPresident of TELA Bio and Director
Roberto E. Cuca J.D.Chief Financial Officer and Chief Operating Officer
Paul TalmoChief Technology Officer
Megan SmeykalVice President, Corporate Controller, Chief Accounting Officer and Principal Accounting Officer
D. Taylor OcasioGeneral Counsel and Corporate Secretary
Jennifer Lou ArmstrongSenior Vice President of Human Resources
Gregory A. FirestoneChief Commercial Officer
Michael LeonardSenior Vice President of Technical Operations
Peter C. MurphyChief Commercial Officer

Latest SEC Filings

DateTypeTitle
Aug 14, 2025SCHEDULE 13G/AFiling
Aug 11, 2025S-8Securities to be offered to employees in employee benefit plans
Aug 11, 202510-QQuarterly Report
Aug 11, 20258-KCurrent Report
Jun 2, 20258-KCurrent Report
May 30, 20258-KCurrent Report
May 30, 2025SCHEDULE 13G/AFiling
May 30, 2025SCHEDULE 13GFiling
May 8, 202510-QQuarterly Report
May 8, 20258-KCurrent Report